Trial
NCT00461812
A Comparison of Mometasone to Advair in Patients With Milder Persistent Asthma
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Johns Hopkins University
Collaborators
Schering-Plough
Condition
Asthma
Intervention
Mometasone
Why stopped
by sponsor due to failure to recruit patients who had mild persistent asthma who were not already on Advair 250/50 or 500/50.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-09-20